Literature DB >> 8792470

Complement and immune complexes.

J A Schifferli1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8792470     DOI： 10.1016/0923-2494(96)87183-5

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  8 in total

1.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

2.  Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.

Authors:  N N Gorgani; J G Altin; C R Parish
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

3.  T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis.

Authors:  K Jiang; Y Chen; C-S Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

4.  Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.

Authors:  Manuela Schönfeld; Ulla Knackmuss; Parul Chandorkar; Paul Hörtnagl; Thomas John Hope; Arnaud Moris; Rosa Bellmann-Weiler; Cornelia Lass-Flörl; Wilfried Posch; Doris Wilflingseder
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

Review 5.  Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity.

Authors:  Wilfried Posch; Marta Bermejo-Jambrina; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  Front Immunol       Date:  2020-11-03       Impact factor: 7.561

Review 6.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

Review 7.  Genetic Insights into the Impact of Complement in Alzheimer's Disease.

Authors:  Megan Torvell; Sarah M Carpanini; Nikoleta Daskoulidou; Robert A J Byrne; Rebecca Sims; B Paul Morgan
Journal:  Genes (Basel)       Date:  2021-12-15       Impact factor: 4.096

Review 8.  Complement, a target for therapy in inflammatory and degenerative diseases.

Authors:  B Paul Morgan; Claire L Harris
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 112.288
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.